Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
- PMID: 20167206
- DOI: 10.1016/j.brainres.2010.02.031
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
Abstract
The present study was undertaken to investigate the neuroprotective effects of resveratrol (RES) on 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD) in rats. PD is an age-related neurodegenerative disorder in which the role of reactive oxygen species (ROS) is strongly implicated. RES, a polyphenolic antioxidant compound enriched in grapes, has been shown to have antioxidant and anti-inflammatory actions and thus was tested for its beneficial effects using 6-OHDA-induced PD rat model. Male Wistar rats were pretreated with RES (20mg/kg body weight i.p.) once daily for 15 days and subjected to unilateral intrastriatal injection of 6-OHDA (10 microg in 0.1% ascorbic acid in normal saline). Three weeks after 6-OHDA infusion, rats were tested for neurobehavioral activity and were killed after 4 weeks of 6-OHDA infusion for the estimation of lipid peroxidation, glutathione content, and activity of antioxidant enzymes (glutathione peroxidase [GPx], glutathione reductase [GR], catalase [CAT], and superoxide dismutase [SOD]. RES was found to be successful in upregulating the antioxidant status and lowering the dopamine loss. Conversely, the elevated level of thiobarbituric acid reactive substances (TBARS), protein carbonyl (PC), and activity of phospholipase A2 in 6-OHDA group was attenuated significantly in RES-pretreated group when compared with 6-OHDA-lesioned group. These results were supported by the immunohistochemical findings in the substantia nigra that has shown the protection of neurons by RES from deleterious effects of 6-OHDA. Thus, RES may be used to reduce the deterioration caused by free radicals thereby preventing subsequent behavioral, biochemical, and histopathological changes that occur during PD.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Free radicals, antioxidant defense systems, and schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:200-6. doi: 10.1016/j.pnpbp.2013.02.015. Epub 2013 Mar 5. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23470289 Review.
-
Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.Pharmacol Biochem Behav. 2006 Jan;83(1):150-60. doi: 10.1016/j.pbb.2006.01.005. Epub 2006 Feb 28. Pharmacol Biochem Behav. 2006. PMID: 16500697
-
Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.Neurobiol Dis. 2006 May;22(2):421-34. doi: 10.1016/j.nbd.2005.12.008. Epub 2006 Feb 9. Neurobiol Dis. 2006. PMID: 16480889
-
Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.J Neurochem. 2005 Apr;93(1):94-104. doi: 10.1111/j.1471-4159.2005.03000.x. J Neurochem. 2005. PMID: 15773909
-
The possible role of iron in the etiopathology of Parkinson's disease.Mov Disord. 1993;8(1):1-12. doi: 10.1002/mds.870080102. Mov Disord. 1993. PMID: 8419792 Review.
Cited by
-
Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria.Psychiatry Clin Psychopharmacol. 2023 Jun 1;33(2):147-155. doi: 10.5152/pcp.2023.23633. eCollection 2023 Jun. Psychiatry Clin Psychopharmacol. 2023. PMID: 38765928 Free PMC article. Review.
-
Aqueous extract of Swietenia macrophylla leaf exerts an anti-inflammatory effect in a murine model of Parkinson's disease induced by 6-OHDA.Front Neurosci. 2024 Feb 21;18:1351718. doi: 10.3389/fnins.2024.1351718. eCollection 2024. Front Neurosci. 2024. PMID: 38449740 Free PMC article.
-
The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model.Saudi Pharm J. 2024 Mar;32(3):101964. doi: 10.1016/j.jsps.2024.101964. Epub 2024 Jan 23. Saudi Pharm J. 2024. PMID: 38328791 Free PMC article.
-
Analysis of phenolic compounds in Parkinson's disease: a bibliometric assessment of the 100 most cited papers.Front Aging Neurosci. 2023 May 2;15:1149143. doi: 10.3389/fnagi.2023.1149143. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37205057 Free PMC article. Review.
-
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155008 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous